After several post communism years on the back burner, Romania's pharmaceutical industry appears resurgent once more.
At the same time private healthcasein is emergent, with a growing number of insurers opting for private medical services, rather than the public ones.
The core attractiveness of the Romanian pharmaceuticals market arises from its significant potential, as the mature markets fail to provide the much sought growth curve, and Big Pharma players chart the emerging markets for alternative revenue sources.
However, local drug companies face pressure from many directions — from the foreboding regulatory palette to competitors with alternative brands, to insurers pushing back on pharmaceutical costs and reimbursement. Whether global pharma companies or a biotechnology startup, accomplishing business goals in such a highly regulated industry requires practical, integrated legal analysis and advice.
We have the background and experience necessary for being creative in sector-specific problem solving. We don’t just know the law; we know the nuances of the law. Thus we provide in-depth analyses and services to overcome all challenges of the sector, in matters like corporate and commercial, general regulatory, manufacturing, marketing and distribution, market introduction, and in all interconnected areas like IP, secrets, copyright and litigation.